Naveed Khan

Naveed Khan is a Director of Commercial and Business Development – Digital Health at BIOTRONIK and has been with the company for 4 years where he has led several innovation initiatives around remote patient monitoring. Naveed is currently supporting the senior leadership team to shape and execute strategic initiatives as part of BIOTRONIK's Digital Health Strategy across targeted markets in Australia, Europe and US. His broad commercial experience (13+ years) spans strategy, product development, corporate innovation and new business development in healthcare markets in US, EU, Japan and Australia across both public and private sectors.

Naveed holds a PhD (Medicine) from the University of Sydney and an Executive MBA from the Melbourne Business School (University of Melbourne).

Microsoft CEO Satya Nadella remarked earlier this year that the first months of the COVID-19 pandemic saw ’two years of digital transformation in two months‘. As the world moved to working, shopping, and socialising online, necessity drove many aspects of healthcare to being delivered remotely too. With vaccines being rolled out around the world and some countries already administering booster shots, it’s time for us to start thinking about post-COVID health care. Where should digital health go now — and what innovations and lessons from COVID-19 should we keep going forward? There’s no doubt the pandemic has accelerated digital health. Although there’s plenty of exciting digital advances, every step forward brings with it new questions for us to tackle. What role should wearables have in diagnosis? What’s next for long-term arrhythmia monitoring? It’s time for us to embrace a new era in digital health. However, for new innovations to truly work for both physicians and patients, we have to help provide answers on everything from diagnostic accuracy to managing workload. Embracing digital change A lot of the digital health changes we’ve seen over the course of the pandemic are probably permanent — especially if, as seems increasingly likely, the virus becomes endemic and never goes away completely. A different state of ‘normal’ will continue to drive ongoing digitalisation. For the most part, I view this as a good thing. To use an example from my native Australia, although we’ve had telehealth for a long time, obtaining reimbursement had been difficult for about ten years. COVID-19 quickly made it a necessity. Now doctors and patients say it’s convenient and leaves them no worse off. It’s especially useful for patients with mobility challenges, such as those whose family members may find it difficult to drive them to follow-up appointments or those living...